{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases", "item": "https://www.patentleaderboard.com/patent/6159978"}]}

Home › Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases

US Patent 6159978 · Granted Dec 12, 2000

Estimated economic value: $8,944,000 ⓘ

Assignee

Aventis Pharmaceuticals Products

Inventors

Michael R. Myers (51 patents)
Alfred P. Spada (55 patents)
Paul E. Persons (37 patents)
Martin P. Maguire (34 patents)

View full patent text on Google Patents →